Gibson Dunn Transaction Named Healthcare, Pharma & Biotech Deal of the Year by The Deal

Accolades  |  September 27, 2021

The Deal

The Deal named “Teledoc acquires chronic care manager Livongo” as its “Healthcare, Pharma & Biotech (Large Cap) Deal of the Year.” Gibson Dunn advised Lazard, financial advisor to Teladoc Health. The awards were announced on September 23, 2021.